Formulary Watch Spotlights
Product Profile: LYNOZYFIC (linvoseltamab-gc)
Product Profile: LIBTAYO (cemiplimab)
Product Profile: JASCAYD (nerandomilast)
Product Profile: JOURNAVX (suzetrigine)
Product Profile: MONJUVI (tafasitamab-cxix injection, for intravenous use)
Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)
Product Profile: REXULTI (brexpiprazole tablet)
Product Profile: MIEBO (perfluorohexyloctane ophthalmic solution)
Product Profile: EYELEA HD (aflibercept injection, solution)
Product Profile: TARPEYO (budesonide capsule, delayed release)
Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Product Profile: XDEMVY (lotilaner ophthalmic solution)
Product Profile: ABILIFY ASIMTUFII (aripiprazole injection, suspension, extended release)
Product Profile: AREXVY (respiratory syncytial virus vaccine, adjuvanted)
Product Profile: ABRYSVO (respiratory syncytial virus vaccine)
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CagriSema reduces HbA1c, weight across T2D spectrum in REIMAGINE trials | ADA 2026
2
Lee Kaplan, M.D., discusses the metabolic case for survodutide | ADA 2026
3
Nearly half of older adults with metastatic lung cancer never receive systemic therapy, study finds
4
Machine learning model predicts T2D risk up to 10 years before onset
5